
Laura Alder, MD, on New Data on Combination Therapy, Immunotherapy, and ADCs in Small Cell Lung Cancer
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOWmFKbG9PcU5GRDlVSERfT29fUjNOM21IVHN3WE9hNDdtUTQwa3NxaUt0Qmpoa0hwRi1KT0ZQMktpNWo3eFdsSmlrSmJZZ0hCRHRFcE9rQ084V1FPeUlvdGxXbTZyN2FfQldqcFhiZ3RFM2l6MUpiYjlMZUg5ZTNQT3NLcDdfbUpFVFJIV2Z6RGF5NGlHRkhOdDVPZENQbUVjSXBF?oc=5" target="_blank">Laura Alder, MD, on New Data on Combination Therapy, Immunotherapy, and ADCs in Small Cell Lung Cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
